Recent Finacing
Recent Raise
Synereca Pharmaceutics is a research-stage biopharmaceutical developing orally active compounds that potentiate antibiotics against drug-resistant Gram-negative bacteria, including colistin potentiators and RecA DNA-repair inhibitors.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors